Resultats de la cerca - Mudi Misgav
- Mostrar 1 - 4 resultats de 4
-
1
-
2
Long‐term patterns of safety and efficacy of bleeding prophylaxis with turoctocog alfa (NovoEight<sup>®</sup>) in previously treated patients with severe haemophilia A: interim res... per Margareth C. Ozelo, Mudi Misgav, F. Abdul Karim, Steven R. Lentz, Mónica Martín‐Salces, Irina Matytsina, Trine Saugstrup, Elena Santagostino
Publicat 2015Carta -
3
-
4
Safety and efficacy of turoctocog alfa (NovoEight<sup>®</sup>) during surgery in patients with haemophilia A: results from the multinational guardian<sup>™</sup> clinical trials per Elena Santagostino, Steven R. Lentz, Mudi Misgav, B. Brand, Pratima Chowdary, Aleksander Savic, Yurdanur Kılınç, Yehuda Amit, A. Amendola, Luigi Piero Solimeno, Trine Saugstrup, Irina Matytsina
Publicat 2014Artigo
Eines de cerca:
Matèries relacionades
Medicine
Haemophilia
Haemophilia A
Internal medicine
Surgery
Adverse effect
Biology
Clinical trial
Paleontology
Pediatrics
Archaeology
Blood product
Clinical endpoint
Coagulation
Cohort
Context (archaeology)
Disease
Guardian
Haemophilia B
History
Interim
Interim analysis
Law
Partial thromboplastin time
Political science
Series (stratigraphy)
Thrombotic microangiopathy